Diabetes is not classified as a cardiovascular disease, but the two conditions are so deeply intertwined that the American Heart Association has called diabetes a major risk factor for cardiovascular disease and stated that “from the point of view of cardiovascular medicine, it may be appropriate to say diabetes is a cardiovascular disease.” That blurring of the line is not just rhetorical. Cardiovascular disease is the leading cause of death among people with diabetes, and having type 2 diabetes roughly doubles your risk of heart attack, stroke, and other cardiovascular events.
How Diabetes Is Officially Classified
In medical classification systems, diabetes is a metabolic disease, not a cardiovascular one. It’s defined by the body’s inability to produce or properly use insulin, which leads to chronically elevated blood sugar. Cardiovascular disease, by contrast, refers to conditions affecting the heart and blood vessels: coronary artery disease, stroke, heart failure, and peripheral artery disease.
The confusion arises because diabetes so reliably leads to cardiovascular problems that some clinicians treat it as a cardiovascular condition in practice. The AHA formally designated diabetes a “major risk factor” for cardiovascular disease, placing it alongside high blood pressure, smoking, and high cholesterol. For treatment purposes, adults aged 40 to 75 with diabetes are recommended cholesterol-lowering medication even without further risk assessment, reflecting how seriously the cardiovascular threat is taken.
Why Diabetes Damages Blood Vessels
Persistently high blood sugar harms the inner lining of blood vessels, a layer called the endothelium. This lining normally keeps blood flowing smoothly, regulates inflammation, and prevents clots. When blood sugar stays elevated, it triggers a cascade of damage: the cells lining your arteries produce excess reactive oxygen species (essentially, harmful molecular byproducts), which interfere with normal cell repair and survival. Over time, these cells die off in a process called apoptosis, leaving patches of exposed artery wall.
Those bare patches act like magnets for trouble. Smooth muscle cells migrate into the gaps, cholesterol deposits accumulate, and the artery wall thickens and stiffens. This is atherosclerosis, the same process behind most heart attacks and strokes. Diabetes accelerates it. High blood sugar also impairs the body’s ability to grow new blood vessels and repair existing ones, compounding the damage year after year.
Large Vessel vs. Small Vessel Complications
Diabetes causes two broad categories of vascular damage. The macrovascular complications, affecting large arteries, are the ones that overlap directly with cardiovascular disease: coronary artery disease, stroke, and peripheral artery disease (reduced blood flow to the legs and feet). These are the major killers.
Microvascular complications affect smaller blood vessels and cause problems that are more uniquely “diabetic”: damage to the kidneys, the retina, and the nerves. While these aren’t classified as cardiovascular disease, they share the same root cause of blood vessel injury from high blood sugar. Someone with diabetes often develops both types simultaneously, which is why managing blood sugar, blood pressure, and cholesterol together matters so much.
The Metabolic Syndrome Connection
Type 2 diabetes rarely shows up alone. It typically arrives alongside a cluster of risk factors known as metabolic syndrome, which directly promotes atherosclerosis and cardiovascular disease. You’re diagnosed with metabolic syndrome if you meet three of these five criteria: a waist circumference above 40 inches for men or 35 inches for women, triglycerides at or above 150 mg/dL, low HDL (“good”) cholesterol, blood pressure at or above 130/85, and fasting blood sugar at or above 100 mg/dL.
Having metabolic syndrome roughly doubles your risk of cardiovascular events. And for people who don’t yet have type 2 diabetes, it increases the risk of developing it about fivefold. This clustering effect is a big reason diabetes and heart disease are so hard to separate. High blood sugar is only one thread in a web that includes inflammation, excess abdominal fat, insulin resistance, and abnormal cholesterol levels, all of which feed into cardiovascular damage.
How Cardiovascular Risk Is Monitored
If you have type 2 diabetes, your doctor is already thinking about your heart, even if you feel fine. Current guidelines recommend moderate-intensity statin therapy for adults with diabetes between 40 and 75 years old as a baseline measure. Routine stress tests or other ischemia screening aren’t recommended for people without symptoms, but one imaging tool has proven useful: coronary artery calcium (CAC) scoring, a quick CT scan that measures calcium deposits in your heart’s arteries.
A CAC score above 100 may prompt your doctor to switch to a more intensive cholesterol-lowering approach or add low-dose aspirin. CAC scoring is also considered reasonable for younger adults (30 to 39) who have had diabetes for many years, and for adults over 75 when it would help guide treatment decisions.
Diabetes Medications That Protect the Heart
One of the most significant shifts in diabetes care over the past decade is the emergence of medications that lower blood sugar and independently reduce cardiovascular risk. Two drug classes stand out.
GLP-1 receptor agonists (injectable medications like semaglutide and liraglutide) reduce major cardiovascular events, including heart attack and stroke, by about 21%. They also lower hospitalization for heart failure. Research suggests these drugs have direct anti-inflammatory and anti-atherosclerotic effects on blood vessels, meaning the heart benefits go beyond just weight loss or blood sugar control.
SGLT2 inhibitors (oral medications like empagliflozin and dapagliflozin) work differently. They reduce pressure on the kidneys and alter how the heart uses energy, producing substantial benefits for heart failure and kidney disease. A large meta-analysis published in Circulation found that combining both drug classes appears to produce independent, additive benefits. In other words, each one protects against cardiovascular damage through a different mechanism, and using them together doesn’t cancel either one out.
This shift in treatment philosophy reflects the broader reality: managing diabetes effectively now means managing cardiovascular risk as a central goal, not an afterthought.
The Practical Takeaway
Diabetes is officially a metabolic disease, not a cardiovascular one. But the distinction is more administrative than biological. The damage diabetes causes to blood vessels is the same process that underlies heart attacks and strokes. Cardiovascular disease remains the most common cause of death in people with diabetes, and every major guideline for diabetes management now includes aggressive cardiovascular risk reduction as a core priority. If you have diabetes, your heart health isn’t a separate concern. It’s the same concern.